Insider Trading & Ownership - Cittadine Andrew

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cittadine Andrew
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-14
Purchase
2022-11-16
4:58 pm
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
16,053$3.0934$49,65924,238
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-12-31
Tax Withholding
2024-01-03
7:39 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
3,098$0.3402142,945
(Direct)
View
2023-12-31
Exercise
2024-01-03
7:39 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
8,952$0142,945
(Direct)
View
2023-09-30
Exercise
2023-10-03
7:30 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
8,953$0146,043
(Direct)
View
2023-09-30
Tax Withholding
2023-10-03
7:30 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
2,624$0.6199146,043
(Direct)
View
2023-06-30
Exercise
2023-07-03
6:51 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
13,841$0148,667
(Direct)
View
2023-06-30
Tax Withholding
2023-07-03
6:51 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
4,057$0.855148,667
(Direct)
View
2023-03-31
Exercise
2023-04-04
5:15 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
4,063$074,490
(Direct)
View
2023-03-31
Tax Withholding
2023-04-04
5:15 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
1,154$1.3974,490
(Direct)
View
2023-02-01
Option Award
2023-02-03
6:44 pm
N/A
2033-02-01
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
180,922$0229,672
(Direct)
View
2022-12-31
Exercise
2023-01-03
4:07 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
4,062$075,644
(Direct)
View
2022-12-31
Tax Withholding
2023-01-03
4:07 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
1,406$2.3775,644
(Direct)
View
2022-09-30
Exercise
2022-10-03
7:42 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
4,063$060,997
(Direct)
View
2022-09-30
Tax Withholding
2022-10-03
7:42 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
1,191$1.5260,997
(Direct)
View
2022-06-30
Exercise
2022-07-01
4:17 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
8,125$062,188
(Direct)
View
2022-06-30
Tax Withholding
2022-07-01
4:17 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
2,812$2.29962,188
(Direct)
View
2022-02-02
Option Award
2022-02-04
7:29 pm
N/A
2032-02-01
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
150,000$0150,000
(Direct)
View
2021-06-30
Option Award
2021-07-02
5:07 pm
N/A
2031-05-31
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
30,000$030,000
(Direct)
View
2021-06-01
Option Award
2021-06-02
4:11 pm
N/A
2031-05-31
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
70,000$070,000
(Direct)
View

Ownership
2021-06-01
8:04 pm
N/A
N/A
Monopar TherapeuticsMNPRCittadine Andrew
Chief Operating Officer
0$070,000
(Direct)
View